Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity.
about
Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?Role of prostaglandins in neuroinflammatory and neurodegenerative diseasesTherapeutic potential of monoacylglycerol lipase inhibitorsNeuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's DiseaseChronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of ADInhibition of soluble tumor necrosis factor ameliorates synaptic alterations and Ca2+ dysregulation in aged ratsGrowth factors in synaptic function.Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid.A role for cyclooxygenase-1 in beta-amyloid-induced neuroinflammation.Omega-3 fatty acids and dementia.Immunoproteasome deficiency alters microglial cytokine response and improves cognitive deficits in Alzheimer's disease-like APPPS1 mice.Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.Effects of collagen-induced rheumatoid arthritis on amyloidosis and microvascular pathology in APP/PS1 mice.Identification of small molecule inhibitors of neurite loss induced by Aβ peptide using high content screening.Probing the biology of Alzheimer's disease in mice.Obovatol improves cognitive functions in animal models for Alzheimer's disease.Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's diseaseThe Potential for Plant Derivatives against Acrylamide Neurotoxicity.Neuroprotective effects of treadmill exercise on BDNF and PI3-K/Akt signaling pathway in the cortex of transgenic mice model of Alzheimer's disease.Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.Neuroinflammation and memory: the role of prostaglandinsExtended results of the Alzheimer's disease anti-inflammatory prevention trial.Peripherally triggered and GSK-3β-driven brain inflammation differentially skew adult hippocampal neurogenesis, behavioral pattern separation and microglial activation in response to ibuprofen.Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection.Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration.Chemical Biology, Molecular Mechanism and Clinical Perspective of γ-Secretase Modulators in Alzheimer's DiseaseIndomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer's disease models.Endoplasmic reticulum stress-mediated hippocampal neuron apoptosis involved in diabetic cognitive impairment.Acetate reduces PGE2 release and modulates phospholipase and cyclooxygenase levels in neuroglia stimulated with lipopolysaccharideA dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease.Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice.Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.Botanical phenolics and brain healthCHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease.Prostaglandin I2 upregulates the expression of anterior pharynx-defective-1α and anterior pharynx-defective-1β in amyloid precursor protein/presenilin 1 transgenic mice.The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's DiseaseNSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.Untangling the Web: Toxic and Protective Effects of Neuroinflammation and PGE2 Signaling in Alzheimer's Disease.Antioxidant gene therapy against neuronal cell death.
P2860
Q26822022-19C1AA28-08DA-4A9F-8038-A9C362CCD64FQ26863534-445FC19A-F333-4E77-B609-24CAAD303D50Q26991513-E3106171-324D-46C5-AF4A-1C9F13BC5FE5Q28074504-05F35A36-0478-4DA8-A9C0-274106C65E9CQ28547449-605FC25B-C166-4BDD-915D-BDEF33E52DC2Q28577238-AB7E6F8F-D50B-49CA-9B26-C4E158C8C4FDQ30449007-DCD6D23A-624E-46CC-AEEC-D7EB4CC0D633Q33588687-66BD4222-59B3-47FA-99A7-6CA0587F8369Q33588710-B864587D-BF4B-480D-805D-433D0E85B450Q33602402-398FE842-4AB9-4F22-86D3-6005C012CD65Q33831029-2497FCDF-FD1C-497E-9308-BB68592098F4Q33904501-AAD90CFF-3832-45B8-AE07-A39D9BD717C3Q34059086-000B0A0A-5C4B-4957-A0ED-21F08A1454EEQ34141136-AD9AEBE7-FB1B-46F3-ABC2-6D96E6257EFFQ34206962-0D4B862B-C77C-47F7-B699-DEF258C154C7Q34243963-0664A36D-48FA-4D8B-8231-7F538F93ABDEQ34306241-064C844E-5446-4EC2-B414-600F4B935B0EQ34472327-088F92E5-C729-409C-A4AA-4DE15B80D40CQ34563358-92CC479E-203D-429D-8363-54BF7909C2BDQ34774194-08E1698F-594A-44E3-AD48-4C0188465B1BQ35072707-603A451D-4961-40ED-B0CF-020B1D113313Q35146385-6A7228E6-1F3F-4ECB-AD50-4F20006F0DC3Q35150206-0D769C69-AAA0-474F-B10C-165DA3D765C0Q35393742-2F1AB227-03F7-4E54-8A1B-A927FAE20079Q35826425-7E4B26E1-3C41-47C1-85E4-471111B2373FQ36081889-F33EBC7F-B4B1-499C-A05F-DF1D25D57C55Q36247082-189D46B4-8274-4F97-AC76-A5CC7E362588Q36848301-1934F3A5-B78F-4EC0-B7EB-8BBF29CB92D9Q36951565-C004CB77-2342-4C40-837A-48F4969B471AQ37025979-49F3E2EF-F06A-4F11-9309-08FD39044A8DQ37081974-3F4DD19C-A955-4237-8ECB-84686CA7EB25Q37190465-D7BF0CF5-FF2E-413D-9FE3-0E4FEC680BB3Q37192900-0EC34AA7-79F6-496D-BEB1-6AB073A349EAQ37230760-71A66805-06D8-4539-9D16-7F2D595A1833Q37235602-A0095CD8-7ADE-44D0-9975-0AFBADF47346Q37261981-4186AA4B-1003-4ACB-8681-5A5B5D812F74Q37452311-795D253E-F478-4181-A769-D546C2C013F2Q37546119-69F3A440-7164-4688-B53F-CA59ACEB12B3Q37588183-FE5BD5F3-182C-465F-AAE3-9324BCE6716EQ37647941-94FAFCD3-147B-439B-A01F-2F612C6D72AC
P2860
Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Cyclooxygenase-2 inhibition im ...... emory and synaptic plasticity.
@en
Cyclooxygenase-2 inhibition im ...... emory and synaptic plasticity.
@nl
type
label
Cyclooxygenase-2 inhibition im ...... emory and synaptic plasticity.
@en
Cyclooxygenase-2 inhibition im ...... emory and synaptic plasticity.
@nl
prefLabel
Cyclooxygenase-2 inhibition im ...... emory and synaptic plasticity.
@en
Cyclooxygenase-2 inhibition im ...... emory and synaptic plasticity.
@nl
P2093
P2860
P356
P1433
P1476
Cyclooxygenase-2 inhibition im ...... emory and synaptic plasticity.
@en
P2093
Agnes Simonyi
Agnieszka Falinska
Giselle P Lim
Grace Y Sun
James Cleary
Karen H Ashe
Kimberly Panizzon
Linda A Kotilinek
Linda H Younkin
P2860
P304
P356
10.1093/BRAIN/AWN008
P407
P577
2008-03-01T00:00:00Z